SurModics
SRDX
#6824
Rank
โ‚น55.37 B
Marketcap
โ‚น3,872
Share price
0.00%
Change (1 day)
13.97%
Change (1 year)
Categories

Revenue for SurModics (SRDX)

Revenue in 2025 (TTM): โ‚น10.28 Billion

According to SurModics's latest financial reports the company's current revenue (TTM ) is โ‚น10.88 Billion. In 2024 the company made a revenue of โ‚น10.76 Billion a decrease over the revenue in the year 2023 that were of โ‚น11.50 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for SurModics from 1998 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น10.28 B-4.41%
2024 โ‚น10.76 B-6.46%
2023 โ‚น11.50 B36.47%
2022 โ‚น8.43 B7.02%
2021 โ‚น7.87 B13.93%
2020 โ‚น6.91 B-3.47%
2019 โ‚น7.16 B18.35%
2018 โ‚น6.05 B31%
2017 โ‚น4.62 B-6.33%
2016 โ‚น4.93 B15.55%
2015 โ‚น4.26 B16.6%
2014 โ‚น3.66 B5.5%
2013 โ‚น3.46 B17.65%
2012 โ‚น2.94 B0.63%
2011 โ‚น2.93 B0.56%
2010 โ‚น2.91 B-17.03%
2009 โ‚น3.51 B-46.44%
2008 โ‚น6.55 B108.22%
2007 โ‚น3.14 B1.36%
2006 โ‚น3.10 B6.6%
2005 โ‚น2.91 B30.14%
2004 โ‚น2.23 B4.07%
2003 โ‚น2.15 B42.59%
2002 โ‚น1.50 B30.13%
2001 โ‚น1.15 B31.07%
2000 โ‚น0.88 B35.78%
1999 โ‚น0.65 B45.99%
1998 โ‚น0.44 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Nektar Therapeutics
NKTR
โ‚น5.63 B-48.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
โ‚น3.940 T 36,104.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
โ‚น2.47 B-77.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
โ‚น137.06 B 1,159.38%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Johnson & Johnson
JNJ
โ‚น8.302 T 76,181.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น3.949 T 36,193.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Agilent Technologies
A
โ‚น611.55 B 5,519.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Heron Therapeutics
HRTX
โ‚น13.97 B 28.39%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
โ‚น302.48 B 2,679.32%๐Ÿ‡บ๐Ÿ‡ธ USA